Petros Grivas

@PGrivasMDPhD · Seattle, WA · joined 16 Jul 2015

Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine

19 228Followers

12 207Following

25 137Posts total

14.3KViews on collected posts

Son gönderiler

Petros Grivas@PGrivasMDPhD12 Sep

@Uromigos @LosUromigos @nataliagandur 1.8K views · 8 likes · 1 reposts · 1 replies Open on X →

Petros Grivas@PGrivasMDPhD11 Sep

⚽🏆 GU oncology has its own World Cup and the trophy is still up for grabs. Brian Rini & @tompowles1 give us a preview of everything coming to Nashville 🎸🇺🇸, Nov 13–14, 2026 for #UromigosLIVE — plus a few thoughts on the other World Cup happening that month 👀 Expect: 🔥 3K views · 9 likes · 2 reposts · 0 replies Open on X →

Petros Grivas@PGrivasMDPhD10 Sep

@eaonc @JCensits 1.2K views · 9 likes · 1 reposts · 0 replies Open on X →

Petros Grivas@PGrivasMDPhD9 Sep

@PGrivasMDPhD @SalvadorjcMD @ruchi1agarwal @montypal @JAMANetworkOpen @OncoAlert @CityofHope_GU @neerajaiims @DrChoueiri @nataliagandur Thank you for engaging with our work Dr. Grivas! 50 views · 1 likes · 0 reposts · 0 replies Open on X →

Petros Grivas@PGrivasMDPhD8 Sep

EA8192, led by @JCensits and @PGrivasMDPhD, is a phase II/III #clinicaltrial of durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy. For more: https://t.co/4dphxuN1s4 #blcsm https://t.co/HkrYNqXxsf

1.5K views · 2 likes · 0 reposts · 0 replies Open on X →

Petros Grivas@PGrivasMDPhD8 Sep

@PGrivasMDPhD @kor_shah @SalvadorjcMD @ruchi1agarwal @montypal @JAMANetworkOpen @OncoAlert @CityofHope_GU @neerajaiims @DrChoueiri @nataliagandur Congratulations to the team! Equity in clinical trials saves lives. But we also need to make sure access reaches the patients and coun 38 views · 1 likes · 0 reposts · 0 replies Open on X →

Petros Grivas@PGrivasMDPhD8 Sep

Congrats @kor_shah @SalvadorjcMD @ruchi1agarwal @montypal et al. for so important paper highlighting relevant disparities in trials availability & stimulating “implementation science” interventions @JAMANetworkOpen @OncoAlert @CityofHope_GU @neerajaiims @DrChoueiri @nataliagandur 3.4K views · 13 likes · 8 reposts · 3 replies Open on X →

Petros Grivas@PGrivasMDPhD7 Sep

@urologysummit #IUCS26 701 views · 3 likes · 0 reposts · 0 replies Open on X →

Petros Grivas@PGrivasMDPhD7 Sep

@VanitaNoronha @urologysummit #IUCS26 674 views · 1 likes · 0 reposts · 0 replies Open on X →

Petros Grivas@PGrivasMDPhD7 Sep

👵🧬 OLD ≠ FRAIL. SCREEN ≠ ASSESS. Excellent and highly practical #IUCS26 talk by @VanitaNoronha on moving beyond chronological age toward physiological reserve and truly right-sized treatment in GU oncology. Key messages: 🔹 G8 / Mini-Cog help identify who needs deeper 956 views · 4 likes · 3 reposts · 0 replies Open on X →

Petros Grivas@PGrivasMDPhD7 Sep

✨️Absolutely, @PGrivasMDPhD what made #IUCS26 so special was not only the outstanding academic level, but also the friendship, camaraderie, and genuine sense of being part of one big GU family.✨️ It was such a pleasure sharing time, experiences, ideas, and knowledge with you 941 views · 3 likes · 1 reposts · 0 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 11 gönderi, 10K–100K takipçi aralığıyla yan yana. geniş kitleye gösteriliyor, ama izleyenlerin azı tepki veriyor.

Medyan görüntülenme956bu hesap99310K–100K için medyan

Erişim, %4.97%bu hesap3.67%10K–100K için medyan

Etkileşim, %0.56%bu hesap1.61%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	956	993	0.96×
Erişim (görüntülenme ÷ takipçi)	4.97%	3.67%	1.35×
Etkileşim oranı	0.56%	1.61%	0.35×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

9417 Sep

956

674

701

3.4K8 Sep

1.5K

509 Sep

1.2K10 Sep

3K11 Sep

1.8K12 Sep

Last 11 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.53%7 Sep

0.84%

0.15%

0.43%

0.74%8 Sep

2.63%

0.20%

2.00%9 Sep

0.81%10 Sep

0.39%11 Sep

0.56%12 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.61%.

What the audience does

Likes67.5%54 in total

Reposts20.0%16 in total

Replies5.0%4 in total

Quotes6.2%5 in total

Bookmarks1.2%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar